Peak Financial Management, Inc. Moderna, Inc. Transaction History

Peak Financial Management, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 29, 2022	SELL	$117.13 - $176.59 $7,613 - $11,478	-65 Reduced 3.22%	1,951 $279,000
Q4 2021 Jan 27, 2022	SELL	$225.82 - $368.51 $36,131 - $58,961	-160 Reduced 7.35%	2,016 $512,000
Q3 2021 Oct 19, 2021	BUY	$221.9 - $484.47 $73,227 - $159,875	330 Added 17.88%	2,176 $837,000
Q1 2021 Apr 29, 2021	SELL	$109.18 - $185.98 $22,927 - $39,055	-210 Reduced 10.21%	1,846 $242,000
Q4 2020 Jan 26, 2021	BUY	$65.74 - $169.86 $135,161 - $349,232	2,056 New	2,056 $215,000

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Peak Financial Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Peak Financial Management, Inc. with notifications on news.